| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/09/2001 | US6171577 Accessible sulfhydryl group; and hexose moiety recognized by a mammalian liver receptor, wherein the hexose moiety is conjugated to the annexin. |
| 01/09/2001 | CA2204640C Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/09/2001 | CA2192079C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 01/08/2001 | CA2274880A1 Icam-6 materials and methods |
| 01/07/2001 | CA2310890A1 L-lysine-producing corynebacteria and process for the preparation of l-lysine |
| 01/07/2001 | CA2310870A1 L-lysine-producing corynebacteria and process for the preparation of l-lysine |
| 01/04/2001 | WO2001001627A2 Server-assisted regeneration of a strong secret from a weak secret |
| 01/04/2001 | WO2001001150A2 Diagnostic test for thrombotic or thromboembolic disease |
| 01/04/2001 | WO2001001144A2 Hybridization of target dna with immobilized nucleic acid analogs |
| 01/04/2001 | WO2001001134A1 A method for diagnosing selected adenocarcinomas |
| 01/04/2001 | WO2001001130A1 METHODS AND COMPOSITIONS RELATING TO PANCREATIC ISLET AND β-CELL DYSFUNCTION |
| 01/04/2001 | WO2001000878A2 A novel vascular endothelial growth factor family member and uses thereof |
| 01/04/2001 | WO2001000877A2 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 01/04/2001 | WO2001000874A2 Cancer associated antigens and uses therefor |
| 01/04/2001 | WO2001000864A2 Nucleic acid binding of multi-zinc finger transcription factors |
| 01/04/2001 | WO2001000855A1 Fusion proteins incorporating lysozyme |
| 01/04/2001 | WO2001000854A2 Chimeric proteins mediating targeted apoptosis |
| 01/04/2001 | WO2001000847A1 Dihydroorotate dehydrogenase sequence of corynebacterium glutamicum and the use thereof in microbial production of pyrimidine and/or compounds used with pyrimidine |
| 01/04/2001 | WO2001000844A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 01/04/2001 | WO2001000843A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2001 | WO2001000842A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 01/04/2001 | WO2001000841A1 Insecticidal proteins from paecilomyces and synergistic combinations thereof |
| 01/04/2001 | WO2001000840A1 Insecticidal and nematicidal proteins |
| 01/04/2001 | WO2001000839A1 Tetanus toxin polypeptides |
| 01/04/2001 | WO2001000838A1 Cloning of basb110 antigen from moraxella (branhamella) catarrhalis |
| 01/04/2001 | WO2001000837A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 01/04/2001 | WO2001000836A1 Novel compounds |
| 01/04/2001 | WO2001000835A1 Moraxella catarrhalis polypeptides |
| 01/04/2001 | WO2001000834A1 Gene affecting male fertility in plants |
| 01/04/2001 | WO2001000833A1 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained |
| 01/04/2001 | WO2001000832A1 Methods for making apo-2 ligand using divalent metal ions |
| 01/04/2001 | WO2001000831A1 Helical polypeptide zalpha29 |
| 01/04/2001 | WO2001000830A1 Sgip peptides |
| 01/04/2001 | WO2001000829A2 Human endogenous retrovirus in breast cancer |
| 01/04/2001 | WO2001000828A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/04/2001 | WO2001000827A1 Apaf-1 compositions and methods to identify apoptosis signalling pathway modulators |
| 01/04/2001 | WO2001000826A2 Novel molecules of the card-related protein family and uses thereof |
| 01/04/2001 | WO2001000825A2 Human chromosome 15 and 16 bardet-biedl syndrome polynucleotides and polypeptides and methods of use |
| 01/04/2001 | WO2001000824A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/04/2001 | WO2001000823A1 NOVEL ISOFORMS OF THE HUMAN ESTROGEN RECEPTOR-$g(a) |
| 01/04/2001 | WO2001000822A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 01/04/2001 | WO2001000818A1 Gene encoding promoter domain of tumor suppressor gene p51 and use thereof |
| 01/04/2001 | WO2001000815A1 Molecular switches |
| 01/04/2001 | WO2001000810A1 Glycoprotein vi and uses thereof |
| 01/04/2001 | WO2001000807A1 MUTATED Nurr1 GENE |
| 01/04/2001 | WO2001000806A2 Dna's encoding proteins with signal peptides |
| 01/04/2001 | WO2001000805A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 01/04/2001 | WO2001000804A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 01/04/2001 | WO2001000803A2 Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof |
| 01/04/2001 | WO2001000801A2 Gene involved in epigenetic gene silencing |
| 01/04/2001 | WO2001000791A1 Stress-responsive induction of a therapeutic agent and methods of use |
| 01/04/2001 | WO2001000790A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 01/04/2001 | WO2001000787A2 Methods of treatment using lig 72a and variants thereof |
| 01/04/2001 | WO2001000784A2 Compound derived from an offset orf of the ice gene |
| 01/04/2001 | WO2001000677A1 A method of modulating integrin mediated cellular activity and agents useful for same |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000675A1 Protamine-free insoluble acylated insulin compositions |
| 01/04/2001 | WO2001000673A1 Membrane-associated and secreted proteins and uses thereof |
| 01/04/2001 | WO2001000672A1 Secreted proteins and uses thereof |
| 01/04/2001 | WO2001000671A1 Derivative compounds |
| 01/04/2001 | WO2001000670A1 Bh3 modified peptides |
| 01/04/2001 | WO2001000669A2 A bap28 gene and protein |
| 01/04/2001 | WO2001000668A1 Extraction of integral membrane proteins |
| 01/04/2001 | WO2001000667A2 Anti-thrombin peptide from anopheles albimanus salivary gland |
| 01/04/2001 | WO2001000666A2 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 01/04/2001 | WO2001000664A2 Secreted alpha-helical protein-36 |
| 01/04/2001 | WO2001000661A2 Carnitine carrier related protein-1 |
| 01/04/2001 | WO2001000655A2 Therapeutic peptides derived from subsequences of bpi |
| 01/04/2001 | WO2001000654A2 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 01/04/2001 | WO2001000649A1 FtsA |
| 01/04/2001 | WO2001000648A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | WO2001000644A1 Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses |
| 01/04/2001 | WO2001000638A2 Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses |
| 01/04/2001 | WO2001000237A1 Synthetic peptide immunogens and antibodies thereto |
| 01/04/2001 | WO2001000235A1 Prion protein binding proteins and uses thereof |
| 01/04/2001 | WO2001000232A2 Use of cpg as an adjuvant for hiv vaccine |
| 01/04/2001 | WO2001000228A1 Method for preventing tumoral growth |
| 01/04/2001 | WO2001000225A1 Hla binding peptides and their uses |
| 01/04/2001 | WO2001000224A1 Compositions and methods for treatment of sexual dysfunction |
| 01/04/2001 | WO2001000221A2 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 01/04/2001 | WO2001000014A2 Test animal for atherosclerosis model and methods for testing and screening |
| 01/04/2001 | WO2001000010A1 Polypeptide compositions formed using a coiled-coil template and methods of use |
| 01/04/2001 | WO2000061611A3 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/04/2001 | WO2000061069A3 Methods and compositions for use in the treatment of hyperlipidemia |
| 01/04/2001 | WO2000060102A3 Bacterial fimbrial system for presentation of heterologous peptide sequences |
| 01/04/2001 | WO2000060082A3 Vesicle associated proteins |
| 01/04/2001 | WO2000058501A3 Novel genetic suppressor elements and methods of making the same |
| 01/04/2001 | WO2000058457A3 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs |
| 01/04/2001 | WO2000058444A3 Adaptation of virus to vertebrate cells |
| 01/04/2001 | WO2000058438A3 Conformationally constrained peptides |
| 01/04/2001 | WO2000056768A3 Chromatographic albumin process |
| 01/04/2001 | WO2000056405A3 Human tumor necrosis factor receptor-like 2 |
| 01/04/2001 | WO2000056358A3 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 01/04/2001 | WO2000055327A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 01/04/2001 | WO2000052162A3 Eukaryotic peptide uptake system for transportation of enkephalins |
| 01/04/2001 | WO2000052045A3 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof |
| 01/04/2001 | WO2000050601A3 Nucleic acid and amino acid sequences of hemoglobin-response genes in candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated candida albicans infection |
| 01/04/2001 | WO2000050586A3 In vitro translation system |
| 01/04/2001 | WO2000050561A3 CaESS1: A CANDIDA ALBICANS GENE, METHODS OF MAKING AND USE |
| 01/04/2001 | WO2000050433A3 Staphylococcus aureus q13 polynucleotides, polypeptides and methods of use |